MDLN

Medline
D

MDLN

Arincen64/100B

Medline financial ratios 2022–2026

58.87 today, against 35.38 on average over the last 5 years.

P/E ratio P/S ratio P/B ratio

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
TTM
26 Sept 2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
Market cap
34.65B34.10B32.27B32.27B32.27B
Enterprise value
43.63B44.73B48.92B47.51B0.00
P/E ratio
58.8729.4326.89137.91—
Forward P/E
25.4427.22———
PEG ratio
8.13————
P/S ratio
1.131.201.271.391.50
P/B ratio
2.943.181.951.90—
P/FCF ratio
18.2926.2922.8122.89—
EV/EBITDA
17.0019.8013.8518.350.00
EV/sales
1.421.571.922.050.00
Earnings yield
2.53%3.40%3.72%0.73%-0.08%
Free cash flow yield
5.47%3.80%4.38%4.37%-0.21%
Dividend yield
—1.52%0.00%0.35%0.00%
Payout ratio
—44.69%0.00%48.72%—
Buyback yield
—5.87%0.06%0.00%0.00%
Shareholder yield
—7.39%0.06%0.35%0.00%
ROE (return on equity)
7.42%10.79%7.26%1.38%—
ROA (return on assets)
2.18%3.01%3.34%0.65%—
ROIC (return on invested capital)
5.09%7.52%6.32%3.44%—
Current ratio
4.044.293.394.13—
Quick ratio
2.372.201.422.13—
Debt to equity
1.071.171.020.99—
Debt / EBITDA
4.905.564.786.50—
Net debt / EBITDA
3.504.704.715.89—
Interest coverage
2.622.721.640.910.96
Asset turnover
0.760.740.710.64—

Each period's market value, at its closing price, over its statements; a quarter over its last four quarters. ROIC is operating income after tax over debt plus equity less cash and short-term investments. The first column is today, at the current price.

Common questions about Medline's ratios

Source: Financial Modeling Prep